Physician Wealth Advisors’s Argan AGX Stock Holding History

Physician Wealth Advisors’s Portfolio AGX Stock Details AGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.39K	Buy	8 +1	+14%	+$665	﹤0.01%	1004
2026 Q1	$3.81K	Hold	7	–	–	﹤0.01%	1100
2025 Q4	$2.19K	Hold	7	–	–	﹤0.01%	1247
2025 Q3	$1.89K	Hold	7	–	–	﹤0.01%	1256
2025 Q2	$1.54K	Buy	+7	New	+$1.26K	﹤0.01%	1157

Other funds holding AGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Physician Wealth Advisors's AGX Position: Q2 2026 in Review

Physician Wealth Advisors increased its Argan (AGX) stake by 14% in Q2 2026, buying an estimated $665 and bringing the position to 8 shares worth $6.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1004.

Physician Wealth Advisors first reported a position in AGX in Q2 2025 and has held it in 5 quarters since. 564 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

Physician Wealth Advisors held 8 shares of Argan worth $6.39K as of Q2 2026.
Physician Wealth Advisors bought 1 Argan share in Q2 2026, an estimated $665.
Argan made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1004 holding.
Physician Wealth Advisors first reported a position in Argan in Q2 2025 and has held it in 5 quarters since.
564 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.